Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Mertens

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Hemasphere|November 15, 2019
From Biology to Therapy: The CLL Success StoryDeyan Y Yosifov, Christine Wolf, Stephan Stilgenbauer, et al.
Leukemia & Lymphoma|August 23, 2016
Rapid detection of ATM/p53 function with p27Kip FACS analysis: a novel diagnostic tool for chronic lympocytic leukemia?Viola Meyer-Pannwitt, Daniela Steinbrecher, Stephan Stilgenbauer, et al.
Veterinary Surgery : VS|June 8, 2018
Protocol changes to reduce implant-associated infection rate after tibial plateau leveling osteotomy: 703 dogs, 811 TPLO (2006-2014)Samantha L Stine, Susan M Odum, W Daniel Mertens
BMC Bioinformatics|October 15, 2024
repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate methodDeyan Yordanov Yosifov, Michaela Reichenzeller, Stephan Stilgenbauer, et al.
Nature Reviews. Cancer|December 4, 2009
From pathogenesis to treatment of chronic lymphocytic leukaemiaThorsten Zenz, Daniel Mertens, Ralf Küppers, et al.
Cancer Treatment Reviews|June 8, 2011
Immune modulatory agents in hematopoietic malignanciesIrina Idler, Nupur Bhattacharya, Hartmut Döhner, et al.
Best Practice & Research. Clinical Haematology|July 13, 2010
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)Thorsten Zenz, Stefan Fröhling, Daniel Mertens, et al.
BMC Research Notes|July 3, 2025
Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samplesDeyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, et al.
British Journal of Haematology|June 10, 2010
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)Angela Philippen, Susanne Diener, Thorsten Zenz, et al.
Scientific Data|May 3, 2020
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyDeyan Yordanov Yosifov, Johannes Bloehdorn, Hartmut Döhner, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Hemasphere|November 15, 2019
From Biology to Therapy: The CLL Success StoryDeyan Y Yosifov, Christine Wolf, Stephan Stilgenbauer, et al.
Leukemia & Lymphoma|August 23, 2016
Rapid detection of ATM/p53 function with p27Kip FACS analysis: a novel diagnostic tool for chronic lympocytic leukemia?Viola Meyer-Pannwitt, Daniela Steinbrecher, Stephan Stilgenbauer, et al.
Veterinary Surgery : VS|June 8, 2018
Protocol changes to reduce implant-associated infection rate after tibial plateau leveling osteotomy: 703 dogs, 811 TPLO (2006-2014)Samantha L Stine, Susan M Odum, W Daniel Mertens
BMC Bioinformatics|October 15, 2024
repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate methodDeyan Yordanov Yosifov, Michaela Reichenzeller, Stephan Stilgenbauer, et al.
Nature Reviews. Cancer|December 4, 2009
From pathogenesis to treatment of chronic lymphocytic leukaemiaThorsten Zenz, Daniel Mertens, Ralf Küppers, et al.
Cancer Treatment Reviews|June 8, 2011
Immune modulatory agents in hematopoietic malignanciesIrina Idler, Nupur Bhattacharya, Hartmut Döhner, et al.
Best Practice & Research. Clinical Haematology|July 13, 2010
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)Thorsten Zenz, Stefan Fröhling, Daniel Mertens, et al.
BMC Research Notes|July 3, 2025
Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samplesDeyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, et al.
British Journal of Haematology|June 10, 2010
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)Angela Philippen, Susanne Diener, Thorsten Zenz, et al.
Scientific Data|May 3, 2020
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyDeyan Yordanov Yosifov, Johannes Bloehdorn, Hartmut Döhner, et al.
Pageof 10